DXH: Transmitters And Receivers, Electrocardiograph, Telephone
What it covers
A telephone electrocardiograph transmitter and receiver is a device used to condition an electrocardiograph signal so that it can be transmitted via a telephone line to another location. This device also includes a receiver that reconditions the received signal into its original format so that it can be displayed. The device includes devices used to transmit and receive pacemaker signals.
The identification in 21 CFR 870.2920, telephone electrocardiograph transmitter and receiver. FDA gives DXH no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K250233 | PreemptiveAI Clinical SDK | Measure Labs, Inc. (Dba Preemptiveai, Inc.) | Feb 13, 2026 | Traditional |
| K250258 | HeartBeam AIMIGo with 12-L ECG Synthesis Software System | Heartbeam, Inc. | Dec 8, 2025 | Traditional |
| K243438 | MEMO Patch M (MPT-E08R-UNC01) | Huinno Co., Ltd. | Dec 5, 2025 | Traditional |
| K243981 | Hexoskin Medical System (7100-00016) | Carre Technologies, Inc. | Nov 18, 2025 | Traditional |
| K243003 | VitalSigns 1-Lead Holter (VSH101) | VitalSigns Technology Co., Ltd. | Jun 17, 2025 | Traditional |
| K233521 | QT ECG (QTERD100) | QT Medical, Inc. | Dec 6, 2023 | Special |
| K222842 | V-Patch Cardiac Monitor | Shandong Corecare Technology Limited | Oct 20, 2022 | Traditional |
| K220795 | QT ECG | QT Medical, Inc. | Sep 26, 2022 | Traditional |
| K213357 | Study Watch with Irregular Pulse Monitor (Home), Study Watch with Irregular Pulse Monitor | Verily Life Sciences, LLC | Jul 19, 2022 | Traditional |
| K220350 | KardiaMobile 6L | AliveCor, Inc. | May 25, 2022 | Traditional |
Clearances by year
48 DXH 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 1 | 382 |
| 2025 | 4 | 322 |
| 2023 | 1 | 35 |
| 2022 | 4 | 150 |
| 2021 | 3 | 107 |
| 2020 | 5 | 141 |
| 2019 | 6 | 177 |
| 2018 | 4 | 294 |
| 2017 | 5 | 150 |
| 2016 | 1 | 190 |
| 2015 | 4 | 142 |
| 2014 | 6 | 186 |
| 2013 | 3 | 206 |
| 2012 | 1 | 86 |
Who submits
31 applicants cleared a DXH device since 2011. 69% of the clearances went to applicants in United States, then Israel (8%), Canada (4%) and Belgium (2%). By type: Traditional 92% and Special 8%. 5 went through a third-party review organization.
| Applicant | Clearances since 2011 |
|---|---|
| AliveCor, Inc. | 10 |
| Nanowear, Inc. | 3 |
| QT Medical, Inc. | 3 |
| Verily Life Sciences, LLC | 3 |
| G-Medical Innovations , Ltd. | 2 |
| Mega Electronics , Ltd. | 2 |
| Advanced Fluidics, LLC | 1 |
| Bioserenity Sas | 1 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 870.2920.
Standards
21 CFR 870.2920 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent DXH clearances declared.
Ask about DXH
Questions about DXH
What is FDA product code DXH?
Product code DXH, “Transmitters And Receivers, Electrocardiograph, Telephone” in FDA's classification database, is a Class II device type under 21 CFR 870.2920 (telephone electrocardiograph transmitter and receiver), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 297 clearances under DXH, 48 of them since 2011.
How many 510(k) clearances are there under DXH?
FDA’s 510(k) database listed 297 clearances under DXH as of Oct 29, 2026, 48 of them decided since 2011; the most recent decision was Feb 13, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a DXH 510(k)?
For the 5 DXH clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 330 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most DXH clearances?
Since 2011: AliveCor, Inc. (10), Nanowear, Inc. (3), QT Medical, Inc. (3), Verily Life Sciences, LLC (3) and G-Medical Innovations , Ltd. (2). 31 applicants have cleared a DXH device in that time.